08:29 AM EDT, 09/03/2024 (MT Newswires) -- Elevai Labs ( ELAB ) said Tuesday that a study showed the potential of its exosome technology in reversing hair thinning and inflammation in participants experiencing hair loss or hair thinning.

The company said participants were given in-office treatment comprising scalp microneedling and application of a topical exosome serum, followed by at-home use of a topical exosome product, on areas of hair thinning.

Elevai Labs ( ELAB ) said results showed ceased crown inflammation, reversal of miniaturized hairs and recovered hair from the dormant phase.

Shares of Elevai Labs ( ELAB ) were up 10% in premarket activity on Tuesday.

Price: 0.2934, Change: +0.03, Percent Change: +10.14